前列腺MRI深度学习模型通过PI-RADS指导的学习有效区分中危病例，在检测csPCa的AUC（0.73-0.88）显著优于放射科医生和临床模型 ...

前列腺MRI靶向活检阴性患者的后续癌症检测率低，临床意义前列腺癌罕见，尤其PI-RADS 3组未检出癌症。基于PI-RADS分类、PSA密度和DRE结果的风险分层管理可减少重复活检需求。 对于PI-RADS 3–5级病变的男性患者，在MRI引导的活检结果为阴性后的最佳随访方案仍存在 ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...

Shifting patterns of care in localized prostate cancer: Impact on patient reported outcome measures (PROMs). This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does ...

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial.

Combining PSA density with prostate MRI findings improves the predictive performance of PI-RADS in men without a prior prostate cancer diagnosis. Combining PSA density (PSAD) with prostate magnetic ...

Getty Images Use of 68 Ga-PSMA PET/CT may avoid unnecessary biopsies in some men with equivocal PI-RADS 3 lesions on mpMRI. Gallium 68-labelled prostate-specific membrane antigen positron emission ...

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...